Steritest Symbio ISL 2 System Pump-Brand Name and Equal (BNE)
FDA · FDA OFFICE OF ACQ GRANT SVCS
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation FDA-RFQ-OC-2026-134494 in this department, oldest first.
- Sep 17, 2026 · this noticeCombined Synopsis/Solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
Notice of Combined Synopsis/Solicitation. This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with part 12. This announcement constitutes the only solicitation; quotes are being requested, and a separate written solicitation will not be issued. The NAICS for this requirement is: 334516. The government is not obligated to make an award. The Government is not obligated to pay costs incurred by the Contractor during quote preparation and quote submission. Background: The National Forensic Chemistry Center (NFCC) in the Office of the Chief… (show all)
Scientist, Office of Specialty Laboratories & Enforcement Support, requires the purchase of one (1) One (1) Steritest Symbio ISL 2 Med US. The Steritest Symbio ISL 2 is designed to fit with the round isolator cut outs and can be installed into the existing NFCC Getinge ISO-FLEX-R Isolator. The Steritest� Symbio ISL Pump is suitable for sterility testing of large and small volume parenteral solutions in glass or plastic bottles, collapsible bags, ampoules, and vials, pre-filled syringes, lyophilized and other soluble products in ampoules or vials, antibiotics in ampoules or vials, medical devices, and difficult-to-dissolve powders. This will not only enable the analysis of forensic and regulatory sterility samples but will also support the development of new methodology for the NFCC and FDA. Minimum Performance Requirements/Salient Characteristics: All of the following system requirements are minimum requirements. Equivalent requirements that differ from these minimum requirements shall be justified by the proposing vendor and evaluated by the NFCC prior to purchase. The System shall have all new components, include all necessary hardware to operate with the following specifications: System to shall be supplied with Steritest Symbio shipping case or equivalent System shall include Steritest Equinox Pressure Control Kit or equivalent System shall include Steritest Pump Footswitch or equivalent System shall include Steritest Symbio Hub Holder or equivalent Pump housing must be stainless steel and be compatible with Vaporized Hydrogen Peroxide decontamination cycle. Must be compatible with prefabricated hole in Getinge IsoFlex-R Isolator All components must be compatible with use within Getinge IsoFlex-R Isolator. Trade and Service Specifications The system must be a newly manufactured unit, not used and refurbished or previously used for demonstration. The Government must be able to expect routine customer service and technical support to be available from the vendor during its lifecycle. A minimum one (1) year warranty on all components Including parts, labor, travel, telephone support, software updates with an option for yearly service agreements. The Contractor shall be responsible for the system during transit. All costs including parts, labor, travel, and other expenses necessary to repair any machine equipment will be borne solely by the contractor at no additional cost to the U.S. Government. Onsite installation and training. The contractor shall conduct one (1) training session for up to three (3) users on-site. The training shall provide a thorough demonstration of all system/solution functions, maintenance, data administration, and basic troubleshooting. The training may be completed on-site immediately after installation/set-up and on-site measurements demonstrating that no damage or misalignment issues arose during transportation and installation but shall be completed no later than 30 days after installation. Unlimited free telephone, e-mail, and/or FAX technical support for one year. Place of Performance: US Food & Drug Administration National Forensic Chemistry Center 6751 Steger Dr. Cincinnati, OH 45237 Period of Performance: Performance begins on the date of formal government acceptance and continues through the end of the manufacturer's warranty period. Quotes are due by email on or before September 22, 2025, by 4:00 P.M. (Eastern Standard Time) and should be sent to brandon.rafus@fda.hhs.gov.
Who won similar work
4 award notices on SAM.gov in the last 24 months. Matched by: Same office (FDA OFFICE OF ACQ GRANT SVCS), same product/service code (PSC) 6640.
Single-winner award sizes (4): middle half $323K to $416K, median $397K; range $123K to $454K.
| Winner | Awards | Value | Last |
|---|---|---|---|
| TURBOFIL PACKAGING MACHINES, LLC | 1 | $454K | Sep 24, 2026 |
| CAPITOL CARBONIC CORP | 1 | $403K | Jan 6, 2025 |
| Atlantic For Services Inc | 1 | $390K | Jan 2, 2025 |
| Z-SPEC, INC. | 1 | $123K | Aug 21, 2026 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- Sep 24, 2026TURBOFIL PACKAGING MACHINES, LLC$454KAutomated Vial Capper Machine and Labeler system
- Aug 21, 2026Z-SPEC, INC.$123KPost-Award Public Notice
- Jan 6, 2025CAPITOL CARBONIC CORP$403KWeekly deliveries of dry ice (solid carbon dioxide)
- Jan 2, 2025Atlantic For Services Inc$390KWeekly deliveries of dry ice (solid carbon dioxide)
Competitive landscape
For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Food & Drug Administration (FDA) since 2024 (0 filings)
- 0 of their lobbyists list a past Food & Drug Administration (FDA) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 129 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.